Genmab A/S (GNMSF) Stock Chart & Stock Price History $225.00 +16.20 (+7.76%) As of 07/23/2025 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock Genmab A/S Stock Price Performance The Genmab A/S (GNMSF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 18.48%, with a year-to-date return of 8.50%. In the past month, the stock has increased 6.59%, reflecting recent market activity. As of the latest close, Genmab A/S traded at $225.00 with a market cap of $14.87 billion and volume of 25 shares. Five years ago, the stock traded at $346.09, representing a 34.99% decrease over that period. At the time, it had a market cap of $22.29 billion and a volume of 104 shares. Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.97%1 Month Performance+6.59%3 Month Performance+10.14%Year-To-Date Performance+8.50%1 Year Performance-18.48%5 Year Performance-34.99% GNMSF Stock Chart for Thursday, July, 24, 2025 GNMSF Chart by TradingView Genmab A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/23/2025$208.80$225.00+7.76%$225.00$225.0025 shs$14.87 billion07/22/2025$214.50$208.80-2.66%$208.80$208.804 shs$13.80 billion07/21/2025$216.40$214.50-0.88%$214.50$214.501 shs$14.17 billion07/18/2025$219.75$216.40-1.52%$216.40$216.408 shs$14.30 billion07/17/2025$214.95$219.75+2.23%$219.75$219.0058 shs$14.52 billion07/16/2025$214.95$214.95$214.95$214.952 shs$14.20 billion07/15/2025$214.95$214.95$214.95$214.952 shs$14.20 billion07/14/2025$214.95$214.95$214.95$214.952 shs$14.20 billion07/11/2025$212.55$214.95+1.13%$214.95$214.952 shs$14.20 billion07/10/2025$215.00$212.55-1.14%$215.30$212.55134 shs$14.04 billion Get the Latest News and Ratings for GNMSF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$198.51$215.00+8.31%$215.00$215.00158 shs$14.21 billion07/07/2025$198.51$198.51$203.00$198.5124 shs$13.12 billion07/04/2025$198.51$198.51$203.00$198.5124 shs$13.12 billion07/03/2025$205.00$198.51-3.17%$203.00$198.5124 shs$13.12 billion07/02/2025$205.00$205.00$205.00$205.0060 shs$13.54 billion07/01/2025$211.09$205.00-2.89%$205.00$205.0060 shs$13.54 billion06/24/2025$211.09$211.09$211.09$209.23330 shs$13.95 billion06/23/2025$211.09$211.09$211.09$209.23330 shs$13.95 billion Related Companies Takeda Pharmaceutical Stock Chart Daiichi Sankyo Stock Chart argenex Stock Chart BeOne Medicines Stock Chart BioNTech Stock Chart Summit Therapeutics Stock Chart Insmed Stock Chart Teva Pharmaceutical Industries Stock Chart Genmab A/S Stock Chart Moderna Stock Chart Receive GNMSF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:GNMSF) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genmab A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Genmab A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNMSF Stock Alerts